News
Stop Losing Money on Generic Prescriptions
One of the most frequent queries our support team receives is: “What should I do when generics costs me more than the tariff?” To help answer this question, we’ve...
Dräger Atlan Anaesthesia workstations: risk of ventilator failure (DSI/2026/005)
Source: MHRA 04.08.2026 In April 2026, Dräger issued a follow-up Field Safety Notice expanding the number of Atlan Anaesthesia workstation devices affected by a manufacturing defect that may result in...
Members Discount on Omnicell Clear MDS Trays!
August 2026 Prices We’re pleased to be able to offer Dispex members exclusive discounts on MDS trays directly from Omnicell! Non-members are also welcome to purchase online at standard rates....
Two places on the Dispensary Managers Mentorship Programme
We’re pleased to announce that two places on the Dispensary Managers Mentorship Programme will become available from 10th August. Places are allocated on a first booked, first paid basis, so...
Stay Informed with the Dispex WhatsApp Support Group!
The group offers a supportive space where you can share best practices, ask questions and exchange knowledge with fellow professionals. Remember, there’s no such thing as a silly question-we’re all here to learn...
Dispex Training Options
Dispex is considered to be the leading educational company in the UK, providing professional training, advice and consultancy which purely focuses on dispensing practices- as well as providing profitability tools...
Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36
Source: MHRA 23.07.2026 Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of...
What Are Dispex Members Talking About?
June – Click here to join. The Dispex WhatsApp group isn’t just expert-led, it’s powered by real-world experience from members facing the same challenges as you every day. Throughout June...
Supporting Your Team Through the Summer Holidays
As we are now in the school summer holidays, and following on from our article, Planning for Summer Holidays and Staff Shortages in Your Dispensary, published on 21st June,...
Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Prolonged-release Tablets, EL(26)A/35
Source: MHRA 20.07.2026 Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL Prolonged-release Tablets, due to the occurrence of...
Meet with the Dispex Team at the DDA Conference
Don’t miss the opportunity to meet the Dispex team at the 2026 DDA Conference and hear from Ankit, and our Lead Training Consultant, Kirstye, as they deliver a must-attend talk...
Unravelling Inclisiran Reimbursement
By Dr Philip Koopowitz Some of you who have been looking at your ePACT Dispensing data might have noticed an anomaly when searching for Inclisiran. BNF Presentation Qty Qty *...
